📈 Markets & Finance
Live
Is Grail (GRAL) Stock a Buy, Sell, or Hold at Under $70?
Written by Leo Sun for The Motley Fool -> Grail’s stock crashed after Galleri’s NHS England trial missed its primary endpoint. But it’s still generating plenty of revenue without an FDA approval. G
Nasdaq News — 1 August 2026
Text:
27
0
0
Grail’s stock crashed after Galleri’s NHS England trial missed its primary endpoint.
But it’s still generating plenty of revenue without an FDA appro
Read Full Story at Nasdaq News → Sources
📈 Markets & Finance
I spent years in finance. Then I realized rural Japan's rice terraces were an overlooked asset.
📈 Markets & Finance
Progressive's Combined Ratio Widened to 87.1 Last Quarter. What That Says About the Growth Machine.
📈 Markets & Finance
Indonesia Stock Market Has Strong Lead
📈 Markets & Finance
Couple holds monthly money dates, avoiding financial arguments for ten years
📈 Markets & Finance
Exxon and Chevron profits surge on rising oil prices due to Iran war
📈 Markets & Finance
Fed rate cuts boost short-term bond ETFs
